Keywords: Evolva, Arpida, Merger and acquisitions, iclaprim

Evolva takes over struggling Swiss bitoech Arpida

Article | 11 September 2009

Privately-held Swiss biotechnology firm Evolva has entered into an agreement with fellow Switzerland-based Arpida to merge, thus rescuing the latter, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in